|
|
|
|
|
|
|
|
|
|
MD News - HIPEC: Furthering Survivorship for GYN Cancer Patients
Monday, March 12, 2012
A team of cancer specialists at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center is among the first in the nation to launch a dedicated gynecologic program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other malignancies.
Q: What is HIPEC, and how is it delivered?
Q: What are the advantages of HIPEC over traditional IV chemotherapy?
Q: I understand UH is planning several research studies on HIPEC. What will they involve?
Q: What do you want physicians to know about HIPEC?
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.